Peter Ballard - DMPK, Oncology, IMED Biotech Unit, AstraZeneca, UK.

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 60 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Material and Supplementary Table 1 from Irreversible Inhibition of EGFR: Modeling the Combined Pharmacokinetic–Pharmacodynamic Relationship of Osimertinib and Its Active Metabolite AZ5104

James W.T. Yates,Susan Ashton,Darren Cross,Martine J. Mellor,Steve J. Powell,Peter Ballard

openalex（2023）

Cited0Views0Bibtex

Supplementary Methods, Supplementary References, Supplementary Tables 1-2, Supplementary Figures 1-3 from Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity

Peter Ballard,James W.T. Yates, Zhenfan Yang, Dong-Wan Kim,James Chih-Hsin Yang,Mireille Cantarini,Kathryn Pickup,Angela Jordan, Mike Hickey,Matthew Grist,Matthew Box,Peter Johnström,Katarina Varnäs,Jonas Malmquist,Kenneth S. Thress,Pasi A. Jänne,Darren Cross

openalex（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn